23.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie
Why Celldex Therapeutics Inc. stock attracts strong analyst attention2x 3x 5x Pick Alert - Newser
Is Celldex Therapeutics Inc. stock a good hedge against inflationFree Market Sentiment Analysis - Newser
Celldex Therapeutics Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia
What drives Celldex Therapeutics Inc. stock priceFree Investment Risk Control - PrintWeekIndia
What analysts say about Celldex Therapeutics Inc. stockConsistently superior profits - Autocar Professional
Is Celldex Therapeutics Inc. a good long term investmentRapidly expanding wealth - jammulinksnews.com
What makes Celldex Therapeutics Inc. stock price move sharplySafety First Trading Signals - Newser
How Celldex Therapeutics Inc. stock performs during market volatility2x Return Forecast - beatles.ru
Celldex Therapeutics (NASDAQ:CLDX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
B-cell Non-hodgkin Lymphoma Clinical Trials, Companies, - openPR.com
Cholera Vaccines Market Deep Research and Growth in Future Scope - openPR.com
Is Celldex Therapeutics, Inc. technically bullish or bearish? - MarketsMojo
(06/24/25) CLDX: A Promising Biotech Name Targeting CSU - moneyshow.com
Chronic spontaneous urticaria improvements persist 28 weeks after barzolvolimab stopped - Healio
Celldex stock price target maintained at $50 by H.C. Wainwright - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):